OKUYAMA Ryo
   Department   Ritsumeikan Asia Pacific University  College of International Management
   Position   Professor
Language English
Publication Date 2025/04
Type Research paper
Peer Review Peer reviewed
Title National Granted Programs and Public Funds for Biopharmaceutical Startups in Japan.
Contribution Type Single Work
Journal Pharmacology Research & Perspectives
Journal TypeAnother Country
Publisher Wiley
Volume, Issue, Page 13,pp.e70106
Authorship Lead author,Corresponding author
Author and coauthor Ryo Okuyama
Details In Japan, biopharmaceutical startups have not been fully nurtured partly due to limited investment. Therefore, government's financial support for those startups is crucial. This study offers a comprehensive overview of the current state of government grants and investments for biopharmaceutical startups in Japan. Both grant programs specifically focused on drug discovery and development and those supporting a broader range of industries, including pharmaceuticals, were identified. Advisory programs affiliated with government agencies that assist biopharmaceutical startups were also identified. Additionally, the government has established four national university funds, which have made investments in biopharmaceutical startups. The relatively small scale of these grants and limited support for seed-stage projects pose significant challenges. Government's consulting services spread across different ministries, highlighting the need for a more unified national approach.
DOI https://doi.org/10.1002/prp2.70106